Tandem Diabetes Care Inc (TNDM)
36.83
+0.99
(+2.76%)
USD |
NASDAQ |
Jan 03, 16:00
36.85
+0.02
(+0.05%)
After-Hours: 20:00
Tandem Diabetes Care Research and Development Expense (Annual): 248.42M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Insulet Corp | 205.00M |
| Haemonetics Corp | 54.44M |
| Masimo Corp | 175.20M |
| Globus Medical Inc | 124.01M |
| Perspective Therapeutics Inc | 21.31M |